Search

Search Constraints

You searched for: Author/Creator Somervaille, Tim C.P.

Search Results

1. Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy. Issue 15 (20th May 2022)

3. Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1. Issue 20 (15th October 2017)

4. Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1. Issue 14 (15th July 2017)

6. Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes. Issue 7 (28th April 2020)